Paper
Discovery of 4-aminomethylphenylacetic acids as γ-secretase modulators via a scaffold design approach.
Published Dec 15, 2011 · Zhili Xin, Hairuo Peng, Andrew Zhang
Bioorganic & medicinal chemistry letters
Q2 SJR score
14
Citations
1
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
4-aminomethylphenylacetic acid 6q effectively reduces brain Aβ42 levels in mice and rats, showing potential as a γ-secretase modulator for Alzheimer's treatment.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...
References
Novel γ-secretase modulators: a review of patents from 2008 to 2010
Novel -secretase modulators (GSMs) show promise in lowering Alzheimer's disease-causing A42 production, but require further understanding of their target(s) for future drug design efforts.
2011·45citations·M. Pettersson et al.·Expert Opinion on Therapeutic Patents
Expert Opinion on Therapeutic Patents
Piperidine-derived gamma-secretase modulators.
Compound 10h, a piperidine-derived gamma-secretase modulator, shows potential as a promising treatment for Alzheimer's disease by decreasing Abeta42 and increasing Abeta38, with excellent pharmacokinetic parameters and CNS penetration in mice.
2010·45citations·A. Hall et al.·Bioorganic & medicinal chemistry letters
Bioorganic & medicinal chemistry letters
Fluorinated piperidine acetic acids as gamma-secretase modulators.
Difluoropiperidine acetic acids effectively lower A42 in a genetically engineered mouse model of APP processing without exhibiting Notch-related effects.
2010·28citations·M. Stanton et al.·Bioorganic & medicinal chemistry letters
Bioorganic & medicinal chemistry letters
Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells
Blocking the Notch and -secretase cascades can turn proliferative cells in intestinal crypts and adenomas into goblet cells, potentially benefiting colorectal neoplastic disease.
2005·1270citations·J. V. Es et al.·Nature
Nature
NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo
NSAIDs and enantiomers of flurbiprofen can lower A42 levels in vivo, potentially reducing the risk of Alzheimer's disease.
2003·550citations·J. Eriksen et al.·Journal of Clinical Investigation
Journal of Clinical Investigation
Ibuprofen Suppresses Plaque Pathology and Inflammation in a Mouse Model for Alzheimer's Disease
Ibuprofen early in Alzheimer's disease can significantly delay some forms of pathology, including amyloid deposition, in a mouse model.
2000·929citations·G. Lim et al.·The Journal of Neuroscience
The Journal of Neuroscience
Exploratory Investigations Probing a Preparatively Versatile, Pyridinium Salt Photoelectrocyclization-Solvolytic Aziridine Ring Opening Sequence.
The novel pyridinium salt photoelectrocyclization-nucleophilic bicyclic aziridine ring opening reaction sequence efficiently produces trans,trans-trisubstituted cyclopentenes, with potential for further applications in organic synthesis.
1996·173citations·R. Ling et al.·The Journal of organic chemistry
The Journal of organic chemistry
Citations
2D QSAR STUDY OF FUSED 5,6-BICYCLIC HETEROCYCLES AS ANTI ALZHEIMER’S AGENTS USING TOPOLOGICAL PARAMETERS
Fused 5,6-bicyclic heterocycles show potential as Alzheimer's agents when analyzed using topological parameters like solvent accessible surface area, valence connectivity index, and shape index.
2023·0citations·S. Misra et al.·Romanian Journal of Biophysics
Romanian Journal of Biophysics
Cellulose Schiff base-supported Pd(II): An efficient heterogeneous catalyst for Suzuki Miyaura cross-coupling
Cellulose-supported Schiff base Pd(II) complex is an efficient catalyst for Suzuki Miyaura cross-coupling, offering high TONs and TOFs, low catalyst loading, and reusability for at least five times.
2021·19citations·P. Pharande et al.·Research on Chemical Intermediates
Research on Chemical Intermediates
Recent developments of small molecule γ-secretase modulators for Alzheimer's disease.
Small molecule -secretase modulators show potential improvements in drug-like properties and are currently in human clinical trials for Alzheimer's disease.
2020·29citations·Shekar Mekala et al.·RSC medicinal chemistry
RSC medicinal chemistry
Carbon Dioxide-Mediated C( sp2)-H Arylation of Primary and Secondary Benzylamines.
Carbon dioxide-mediated ortho-arylation of primary and secondary benzylamines using PdII allows for milder conditions and direct use of free amine products without deprotection.
2018·49citations·M. Kapoor et al.·Journal of the American Chemical Society
Journal of the American Chemical Society
Kinetic Resolution of Benzylamines via Palladium(II)-Catalyzed C-H Cross-Coupling.
Pd(II)-catalyzed enantioselective C-H cross-coupling of benzylamines via kinetic resolution provides high enantiomeric purity for chiral benzylamines and ortho-arylated benzylamines, potentially
2016·56citations·Kai-Jiong Xiao et al.·Journal of the American Chemical Society
Journal of the American Chemical Society